News
IDIBELL becomes a member of the Pessics de Ciència Scientific Committee
IDIBELL, together with other scientific institutions in Catalonia, is already part of the Scientific Committee for Pessics de Ciència.
The Department of Research and Universities produces a video on IDIBELL’s biomedical research to promote scientific vocations among young people
The second edition of the RECERCLIPS collection explains genetics research at IDIBELL and is presented by the youtuber Juliana Canet.
Research is written in feminine: IDIBELL women and their career
The glass ceiling, family reconciliation and gender stereotypes are barriers that have had to be overcome, but they have not been an impediment to becoming the leading scientists today.
Researchers identify the biological basis responsible for developing breast cancer in patients with mutations in BRCA1
A study by IDIBELL and ICO, published in the journal Nature Communications, indicates that overexpression of the HMMR gene in women with BRCA1 mutations alters key cellular processes and accelerates the development of breast cancer.
Researchers identify a gene that causes a new neurological and bone syndrome
An international team led by IDIBELL and Necker Hospital in Paris has identified mutations in the SLC35B2 gene as responsible for a syndrome that, although very rare and hitherto unknown, could be affecting hundreds of people around the world who would still remain undiagnosed. Symptoms of this disorder include neurodevelopmental delay, motor dysfunctions, and deformity […]
Pharmacological inhibition of a protein reduces metastases in Ewing’s Sarcoma in vivo and in vitro models
The G9a enzyme increases the probability of developing metastases in these bone or soft tissue neoplasms. However, treatment with its inhibitor (BIX01294) could improve the control of metastasis in patients.
A study shows that the pathogen H. influenzae type f is genetically stable
A study published in the journal Scientific Reports, carried out by the Bacterial Epidemiology research group at IDIBELL, Bellvitge Hospital, and CIBERES, has studied the diversity of genes present in clinical strains of H. influenzae serotype f.
How does antiangiogenic therapy increase the aggressiveness of tumors?
An article of the IDIBELL and ICO Tumor Angiogenesis Research Group reviews the mechanisms involved in the increased tumor aggressiveness induced by antiangiogenic therapy.
An international clinical trial shows the benefits of a drug in patients hospitalized with acute cardiac dysfunction
According to the results of the EMPULSE phase III clinical trial, patients admitted for acute heart failure are 36% more likely to experience improvement within 90 days of receiving treatment with empagliflozin, an existing drug that is mostly prescribed for type 2 diabetes. Dr. Josep Comin, head of the Cardiovascular Disease research group and head […]